Steven H. Krasnow

1.6k total citations
42 papers, 1.2k citations indexed

About

Steven H. Krasnow is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Steven H. Krasnow has authored 42 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 10 papers in Pulmonary and Respiratory Medicine and 10 papers in Oncology. Recurrent topics in Steven H. Krasnow's work include Head and Neck Cancer Studies (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Steven H. Krasnow is often cited by papers focused on Head and Neck Cancer Studies (4 papers), Erythrocyte Function and Pathophysiology (3 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers). Steven H. Krasnow collaborates with scholars based in United States, Mexico and Puerto Rico. Steven H. Krasnow's co-authors include Martin H. Cohen, Robert G. Wadleigh, Marc L. Citron, Kirk V. Shepard, Terry F. Plasse, Montague Lane, Samir K. Ballas, Monica B. Spaulding, Robert W. Gorter and Barbara G. Bokhour and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and Cancer.

In The Last Decade

Steven H. Krasnow

38 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Steven H. Krasnow United States 17 358 249 228 211 147 42 1.2k
Andreas Böck Switzerland 24 373 1.0× 56 0.2× 464 2.0× 119 0.6× 148 1.0× 49 1.9k
Felix Momm Germany 21 342 1.0× 203 0.8× 158 0.7× 119 0.6× 98 0.7× 60 1.3k
David Voss New Zealand 19 304 0.8× 50 0.2× 218 1.0× 104 0.5× 50 0.3× 62 1.4k
A. Prins Netherlands 21 124 0.3× 207 0.8× 194 0.9× 60 0.3× 89 0.6× 25 1.2k
Michael Eaddy United States 21 234 0.7× 203 0.8× 180 0.8× 157 0.7× 170 1.2× 96 1.5k
Dong Chan Jin South Korea 26 256 0.7× 62 0.2× 300 1.3× 48 0.2× 96 0.7× 78 2.0k
Gerhardt Pohl United States 16 193 0.5× 482 1.9× 170 0.7× 30 0.1× 35 0.2× 43 1.3k
E. Neugebauer Germany 21 151 0.4× 200 0.8× 752 3.3× 118 0.6× 49 0.3× 80 2.1k
Claire Le Jeunne France 24 273 0.8× 56 0.2× 111 0.5× 111 0.5× 138 0.9× 122 1.5k
Rita Wickham United States 16 220 0.6× 567 2.3× 234 1.0× 28 0.1× 148 1.0× 38 1.1k

Countries citing papers authored by Steven H. Krasnow

Since Specialization
Citations

This map shows the geographic impact of Steven H. Krasnow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven H. Krasnow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven H. Krasnow more than expected).

Fields of papers citing papers by Steven H. Krasnow

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven H. Krasnow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven H. Krasnow. The network helps show where Steven H. Krasnow may publish in the future.

Co-authorship network of co-authors of Steven H. Krasnow

This figure shows the co-authorship network connecting the top 25 collaborators of Steven H. Krasnow. A scholar is included among the top collaborators of Steven H. Krasnow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven H. Krasnow. Steven H. Krasnow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Diao, Guoqing, et al.. (2023). The prevalence and clinical significance of HER2 expression in prostate adenocarcinoma. Annals of Diagnostic Pathology. 67. 152219–152219. 8 indexed citations
2.
Aggarwal, Anita, David J. Maron, & Steven H. Krasnow. (2017). Breast cancer in male veterans: The Veterans Affairs (VA) informatics and computing infrastructure (VINCI) big data analysis.. Journal of Clinical Oncology. 35(15_suppl). 1559–1559. 1 indexed citations
3.
Krasnow, Steven H., et al.. (2015). Role of prophylactic PEG and risk factors for PEG dependency in head and neck cancer patients undergoing radiotherapy.. Journal of Clinical Oncology. 33(15_suppl). e17017–e17017. 1 indexed citations
4.
Aggarwal, Anita, Min-Ling Liu, & Steven H. Krasnow. (2014). Breast cancer in male veteran population: an analysis from VA cancer registry. The Journal of Community and Supportive Oncology. 12(8). 293–297. 8 indexed citations
5.
Bhoopalam, Nirmala, Thomas Moritz, Harinder S. Garewal, et al.. (2008). A PHASE III TRIAL OF ZOLEDRONIC ACID (Z) TO PREVENT OSTEOPOROSIS IN MEN ON EARLY VS. PROLONGED ANDROGEN DEPRIVATION THERAPY (ADT) IN A HIGH RISK VA POPULATION. The Journal of Urology. 179(4S). 252–252.
6.
Krasnow, Steven H., et al.. (2003). Sodium-Wasting Nephropathy Caused by Cisplatin in a Patient with Small-Cell Lung Cancer. Clinical Lung Cancer. 5(3). 187–189. 26 indexed citations
7.
Needles, Burton, Eduardo Miranda, Jesse I. Spector, et al.. (1999). A multicenter, double-blind, randomized comparison of oral ondansetron 8 mg b.i.d., 24 mg q.d., and 32 mg q.d. in the prevention of nausea and vomiting associated with highly emetogenic chemotherapy. Supportive Care in Cancer. 7(5). 347–353. 7 indexed citations
8.
Sharma, Daya Nand, et al.. (1997). Sequential Chemotherapy and Radiotherapy for Squamous Cell Esophageal Carcinoma. American Journal of Clinical Oncology. 20(2). 151–153. 9 indexed citations
9.
Patterson, Robert H., et al.. (1996). Porocarcinoma of the heel: A case report with unusual histologic features. Cancer. 78(4). 751–757. 22 indexed citations
10.
Patterson, Robert H., et al.. (1996). Porocarcinoma of the heel: A case report with unusual histologic features. Cancer. 78(4). 751–757. 1 indexed citations
11.
Nylén, Eric, James L. Hall, Steven H. Krasnow, Kenneth L. Becker, & Robert G. Wadleigh. (1994). Nonsurgical Closure of Esophago–Respiratory Fistulas: Role for the Somatostatin Analogue Octreotide Acetate?. The American Journal of the Medical Sciences. 308(3). 152–156. 4 indexed citations
12.
Malik, Shakun, Steven H. Krasnow, & Robert G. Wadleigh. (1994). Closure of tracheoesophageal fistulas with primary chemotherapy in patients with esophageal cancer. Cancer. 73(5). 1321–1323. 17 indexed citations
13.
Redman, Robert S., et al.. (1992). Evaluation of the carcinogenic potential of toluidine blue O in the hamster cheek pouch. Oral Surgery Oral Medicine Oral Pathology. 74(4). 473–480. 17 indexed citations
14.
Cohen, Martin H., Steven H. Krasnow, Samuel V. Spagnolo, et al.. (1991). Continuous Intravenous Infusion of Morphine for Severe Dyspnea. Southern Medical Journal. 84(2). 229–234. 64 indexed citations
15.
Plasse, Terry F., Robert W. Gorter, Steven H. Krasnow, et al.. (1991). Recent clinical experience with dronabinol. Pharmacology Biochemistry and Behavior. 40(3). 695–700. 172 indexed citations
16.
Krasnow, Steven H., et al.. (1989). Thrombosis: The Major Hickman Catheter Complication in Patients with Solid Tumor. CHEST Journal. 95(1). 71–75. 97 indexed citations
17.
Citron, Marc L., et al.. (1987). Clearance of Continuous Intravenous Morphine for Severe Cancer Pain. Drug Intelligence & Clinical Pharmacy. 21(12). 981–985.
18.
Cohen, Maurice, Anita Johnston-Early, Margaret Hood, et al.. (1985). Drug precipitation within i.v. tubing: a potential hazard of chemotherapy administration.. PubMed. 69(11). 1325–6. 9 indexed citations
19.
Ballas, Samir K. & Steven H. Krasnow. (1981). Balanced globin synthesis in idiopathic myelofibrosis. Clinica Chimica Acta. 110(2-3). 255–259. 3 indexed citations
20.
Ballas, Samir K. & Steven H. Krasnow. (1980). Structure of erythrocyte membrane and its transport functions.. PubMed. 10(3). 209–19. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andreas Böck Breakdown of academic impact, for papers by Felix Momm Breakdown of academic impact, for papers by David Voss Breakdown of academic impact, for papers by A. Prins Breakdown of academic impact, for papers by Michael Eaddy Breakdown of academic impact, for papers by Dong Chan Jin Breakdown of academic impact, for papers by Gerhardt Pohl Breakdown of academic impact, for papers by E. Neugebauer Breakdown of academic impact, for papers by Claire Le Jeunne Breakdown of academic impact, for papers by Rita Wickham
Rankless by CCL
2026